Tio-Gillen AP - Search Results

1

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.

Kuitwaard K, de Gelder J, Tio-Gillen AP, Hop WC, van Gelder T, van Toorenenbergen AW, van Doorn PA, Jacobs BC. Kuitwaard K, et al. Ann Neurol. 2009 Nov;66(5):597-603. doi: 10.1002/ana.21737. Ann Neurol. 2009. PMID: 19938102 Clinical Trial.

2

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.

Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG. Jacobs BC, et al. Ann Neurol. 1996 Aug;40(2):181-7. doi: 10.1002/ana.410400209. Ann Neurol. 1996. PMID: 8773599

3

Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.

Jacobs BC, van Doorn PA, Groeneveld JH, Tio-Gillen AP, van der Meché FG. Jacobs BC, et al. J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):641-3. doi: 10.1136/jnnp.62.6.641. J Neurol Neurosurg Psychiatry. 1997. PMID: 9219756 Free PMC article.

4

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA. Ang CW, et al. Infect Immun. 2002 Mar;70(3):1202-8. doi: 10.1128/IAI.70.3.1202-1208.2002. Infect Immun. 2002. PMID: 11854201 Free PMC article.

5

Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.

Ang CW, Tio-Gillen AP, Groen J, Herbrink P, Jacobs BC, Van Koningsveld R, Osterhaus AD, Van der Meché FG, van Doorn PA. Ang CW, et al. J Neuroimmunol. 2002 Sep;130(1-2):179-83. doi: 10.1016/s0165-5728(02)00209-6. J Neuroimmunol. 2002. PMID: 12225900

6

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.

Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA. Geleijns K, et al. J Neuroimmunol. 2004 May;150(1-2):132-8. doi: 10.1016/j.jneuroim.2004.01.003. J Neuroimmunol. 2004. PMID: 15081257

7

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

8

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC. Kuijf ML, et al. J Neurol Sci. 2005 Dec 15;239(1):37-44. doi: 10.1016/j.jns.2005.07.009. Epub 2005 Sep 8. J Neurol Sci. 2005. PMID: 16154154

9

Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

Godschalk PC, Gilbert M, Jacobs BC, Kramers T, Tio-Gillen AP, Ang CW, Van den Braak N, Li J, Verbrugh HA, Van Belkum A, Endtz HP. Godschalk PC, et al. Microbes Infect. 2006 Jan;8(1):248-53. doi: 10.1016/j.micinf.2005.06.022. Epub 2005 Sep 13. Microbes Infect. 2006. PMID: 16213180 Free article.

10

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC. Geleijns K, et al. J Immunol. 2006 Sep 15;177(6):4211-7. doi: 10.4049/jimmunol.177.6.4211. J Immunol. 2006. PMID: 16951387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters